Inventory

3 Months Ended

Mar. 31, 2023

Components of inventory, net of reserves, as of March 31, 2023 and December 31, 2022 are as follows (table in thousands):


	March 31, 2023		December 31, 2022
Inventory - Current Portion
Raw Materials	$	2,806	$	3,351
Work in Process	504		351
Finished Goods	2,285		2,112
Total Current Inventory	5,595		5,814
Inventory - Long Term	1,276		1,276
Total Inventory	$	6,871	$	7,090

As of both March 31, 2023 and December 31, 2022, the Company classified $1.3 million of inventory as non-current, all of which was related to Triferic raw materials. This Triferic inventory will be utilized for the Company's international partnerships. The Company has discontinued its New Drug Applications ("NDAs") for Triferic (dialysate) and Triferic AVNU in the United States. As of both March 31, 2023 and December 31, 2022, the total Triferic inventory net of reserve was $1.3 million. As of March 31, 2023 and December 31, 2022, Rockwell had total Concentrate inventory aggregating $5.6 million and $5.8 million, respectively, against which Rockwell had reserved $25,000 for both periods.